Evaluating the mySugr app for adults with type 1 diabetes

INTERVENTION: Participants randomised to the intervention group will be asked to use the pro version of the 'mySugr' app for 12 weeks. MySugr is a diabetes management app that allows users to log and keep track of changes in their blood glucose levels, HbA1c levels, body weight, medication, meals, carbohydrate intake, insulin, and physical activity. Users can also set reminders and goals related to the management of their diabetes. In addition, the mysugr app analyses the information logged and creates daily, weekly and monthly reports allowing users to evaluate how well they meet the goals set. Participants can use any of the features of the app over the 12‐week period. They will be encouraged to use the app daily and will be sent text message reminders to use the app once every 2 weeks. CONDITION: Metabolic and Endocrine ‐ Diabetes Type 1 diabetes; ; Type 1 diabetes PRIMARY OUTCOME: Glycaemic control will be assessed by glycated haemoglobin (HbA1c) levels. This information is collected as part of standard care and will be obtained from patient medical records.[The most recent HbA1c collected prior to intervention, at completion of the 12‐week intervention (primary timepoint), and 6‐months after randomisation ] SECONDARY OUTCOME: Diabetes distress will be assessed using the Problem Areas in Diabetes (PAID) questionnaire.[Baseline and at completion of the 12‐week intervention] Diabetes self‐efficacy will be assessed using the Diabetes Self Efficacy Scale (DSES). The scale measures patient’s perceived self‐efficacy in managing diabetes.[Baseline and at completion of the 12‐week intervention] For participants in the intervention group only, engagement with the MySugr will be assessed using the end user version of the Mobile Application Rating Scale (MARS). It is a 20‐item scale that assesses the quality of mobile health apps based on engagement, functionality, aesthetics, quality of information, and subjective quality. [At completion of the 12‐week intervention] Optimism will be assessed using the revised version of the Life Orientation Test (LOT‐R). [Baseline and at completion of the 12‐week intervention] Quality of life will be assessed using the World Health Organisation‐Five Well‐Being Index (WHO‐5). [Baseline and at completion of the 12‐week intervention] Self‐care behaviours will be assessed using the Self‐Care Inventory‐Revised Version (SCI‐R). The scale measures patients adherence to diabetes treatment regimen and recommended lifestyle changes.[Baseline and at completion of the 12‐week intervention] The Perceived Stress Scale (PSS‐10) will be used to assess stress. It is a 10‐item scale that assesses the extent to which individuals perceive events as stressful in the previous month[Baseline and at completion of the 12‐week intervention] INCLUSION CRITERIA: Inclusion criteria are: (1) a diagnosis of type 1 diabetes >1 year; (2) 18 years of age or older; (3) ability to speak, read and understand English and provide informed consent; (4) own an iOS or android smartphone that can download apps